Herpes simplex virus vectors bearing a glu cose transporter (GT) gene and a marker gene were found to protect neurons against a I-h focal ischemic insult. Rats receiving the GT vector vo.22(3galo.4GT exhibited a 67.4 ± 35.3% survival of virally targeted neurons in the ischemic hemisphere compared with the contralateral control (n = 7), whereas rats receiving a control vector exhibited only 32.8 ± 17.9% survival (n = 9). This sig-Neurons are highly susceptible to the hypoxia ischemia that occurs duri n g stroke. Due to their nonreplaceable post-mitotic nature, it is essential that effective protective interventions be developed to prevent neuron death. Because of these same properties, however, the development of such in terventions demands novel therapeutic approaches. With the recent advent of herpes simplex virus (HSV) and other viral vectors that are capable of overexpressing exogenous genes in mature neu rons, the possibility of achieving neuroprotection by direct gene transfer has emerged. HSV vectors afford the advantage of being both neurotropic and capable of packaging large amounts of DNA for de livery to nondividing CNS neurons (Glorioso et aI. , 1992). Employing such vectors, we have chosen as a principal target the energetic deficits intrinsic to many neurologic crises. An HSV vector, designated vo22l3gala4GT, was generated bearing the glut-I
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nificant improvement in survival (105%, p = 0.022) sug gests that energy failure is an important contributor to the neuropathology of ischemic damage in the striatum, and that it can be alleviated by gene transfer. This is the first demonstration of protection against ischemic cerebral in jury by the direct transfer of GT genes to neurons. Key Words: Gene transfer-Herpes simplex-Hypoxia ischemia-Glucose transport-Neuroprotection.
gene encoding the GLUT-l isoform of the rat brain glucose transporter (GT) and the Escherichia coli lacZ marker gene. We have previously demon strated that such GT vectors increase glucose up take in neurons both in vitro and in vivo (Ho et aI., 1993) , and that this enhanced uptake protects a va riety of cultured neurons against an array of meta bolic and excitotoxic insults (Ho et aI., 1995; Lawrence et aI. , 1995) , and against seizure-induced (Lawrence et aI. , 1995) and antimetabolite-induced neuronal damage in vivo (R. Dash et aI. , 1995) .
With a cessation of blood flow during stroke, there is a failure of glucose delivery and shift to less efficient anaerobic metabolism. Thus, stroke repre sents a significant energetic crisis to the affected neuron populations (Auer and Siesjo, 1988; Beal et aI. , 1991; Sapo\sky, 1992) . In this report we have investigated the potential neuroprotective effects of overexpressing the glucose transporter in neurons within the striatum before a transient focal ischemia induced by a I-h middle cerebral artery occlusion (MCAO).
MATERIALS AND METHODS
HSV vectors were generated by harnessing the natural packaging properties of the virus (Spaete and Frenkel, 1982; Ho et aI., 1993) . As previously described (Lawrence et aI., 1995) , the plasmid p0:22f3gal0:4GT was constructed containing the HSV origin of replication and packaging sequences and the rat brain glut-l gene and the Escherichia coli lacZ gene under the control of the HSV 0:4 and 0:22 promoters, respectively. This plasmid was transfected into E5 cells, which are stably trans fected with the HSV immediate early gene 0:4. Superin fection of the E5 cells with the HSV deletion mutant d120, lacking the 0:4 gene, gave rise to vectors, designated v0:22f3gal0:4GT, bearing concatemers of the plasmid and replication-incompetent helper virus particles at a ratio of 1:2 (Lawrence et aI., 1995) . Previous investigations had demonstrated that such vector/helper virus stocks were not cytopathic when delivered to the striatum at the titers employed (Ho et aI., 1994) and that they significantly en hanced glucose uptake in targeted neurons as assessed by 2-deoxy[14C]glucose uptake (Ho et aI., 1993) . A control vector, designated v0:22f3gal0:4gts, was generated bearing the glut-l gene with the insertion of a stop codon so as to produce a truncated dysfunctional gene product (Lawrence et aI., 1995) .
After microconcentration of viral stocks 5-1O-fold in Microcon 100-kDa microfiltration devices (Amicon), 6 !-ll of either v0:22f3gal0:4GT or v0:22f3galo:4gts was delivered bilaterally to the striatum of 350-400-g Sprague-Dawley rats (from bregma: AP = 0, ML = 3.5, with two injection sites of 3 !-ll each at DV = 4.5 and 3.5 mm; vector titer of 1 x 106 infectious particles/ml, helper virus titer of 2 x 106 plaque forming units/m\). Six hours later ischemia was induced by the insertion of an intraluminal 3-0 nylon su ture through the common carotid artery to the branch point of the MCA and the anterior cerebral artery, result ing in the occlusion of the MCA and the reduction of collateral blood flow from the anterior and posterior ce rebral arteries (Longa et aI., 1989; Memezawa et aI., 1992; Yoon and Steinberg, 1994) . To confirm in vivo co expression of the glut-l and lacZ genes, one rat from each treatment group was killed 24 h after viral infusion with out being subjected to MCAO. Brains were frozen in 2-methylbutane ( -20°C) and 5 !-lm coronal sections were taken at the site of injection. Sections were then labeled with anti-f3-galactosidase mouse monoclonal antibody (1 :20; Sigma), and anti-GT rabbit serum (l: 100; East Acres Biologicals), followed by goat anti-rabbit antibody conjugated to rhodamine (1: 100; Vector Laboratories) and goat anti-mouse antibody conjugated to fluorescein (1: 20; Vector Laboratories). G T and f3-gal signal was de tected and photomicrographs were taken on a fluorescent microscope with a lOOx objective.
Brain sections from the occluded animals were pre pared as previously described (Lawrence et aI., 1995) . Briefly, animals were killed and perfused with 4% paraformaldehyde 48 h after the occlusion. After postfix ing, 25-l-lffi frozen sections were taken at 50-!-lm incre ments 1 mm anterior and posterior to the infusion site. Slices were stained with 3-bromo-4-chloro-5-indoyl galacto-pyranoside (X-gal) and cresyl violet to allow the identification of healthy, intact, virally targeted neurons and to assess the extent of stroke-induced damage. The number of positive-staining blue neurons were counted at 40x magnification in successive sections within each stri atum by a researcher blind to the identity of the experi mental groups. Relative survivorship of vector targeted neurons for each brain were expressed as the ratio of the total number of positive neurons in the occluded hemi- Vol. 16, No.2, 1996 sphere versus the number in the unoccluded control hemisphere. Infarct damage within the striatum was as signed a degree of severity on a scale of 0-5, in which 0 represented no visible damage in the occluded hemi sphere under 20x magnification and 5 represented com plete ablation of the striatum and surrounding cortex. Those brains exhibiting 0 damage were not included in the analysis and a comparison of damage between GT and control groups was made using a X2 test. A comparison of lacZ-positive neuron survivorship between GT and con trol groups was performed by analysis of variance, and a comparison of the number of surviving neurons in the occluded hemispheres of each brain to their own contra lateral controls within each group was made using a paired Student's t test.
RESULTS AND DISCUSSION
Modeling stroke by the temporary occlusion of the MeA results in lesions within the medial and lateral striatum, and overlying cerebral cortex (Longa et ai., 1989; Memezawa et ai., 1992; Yoon and Steinberg, 1994) . Delivery of both va22pgala4GT and va22pgala4gts before the occlu sion gave rise to the,expression of lacZ in striatal neurons, some of which lay within the lesioned cell field ( Fig. 1 A-F) . Delivery of the vectors va22pgala4GT, but not va22pgala4gts, gave rise to coexpression of Glut-l and lacZ as assessed by dou ble immunofluorescence ( Fig. IG and H) . We have previously demonstrated by immunofluorescence that the expression of lacZ in cultured Vero cells infected with va22pgala4GT is virtually always ac companied by the strong coexpression of GT (Lawrence et ai., 1995) , and now finding that the same is true in striatal neurons in vivo, we interpret positive striatal neuron lacZ staining to indicate overexpression of GT within these cells. Likewise, the morphological characteristics of lacZ-positive cells, and previous demonstrations of the strong propensity of HSV vectors to infect neurons rather than glia in cell culture and in the intact brain (Ho et ai., 1993; Lawrence et ai., 1995) , led us to conclude that the cells included in our analysis were striatal positive neurons in the contralateral control hemi sphere, was significantly greater in animals receiv ing the GT vector (67.4 ± 35.3%) than in animals receiving the control vector (32.8 ± 17.9%; p = 0.022) (Fig. 2) . Brains in GT and control groups exhibited no significant difference in the amount of total damage within the region of infusion (GT dam age = 3.43 ± 1.13; control damage = 3.44 ± 1.01; X2 = 0.237, n. s.); hence, the differential survivor ship cannot be attributed to differing degrees of hypoxia-ischemia endured. The results suggest, in stead, that enhanced glucose uptake can protect striatal neurons in the face of hypoxic-ischemic in sults. The possibility that the GT overexpression merely acts to slow neuron death, and hence, con tribute to a greater number of surviving neurons at the 48-h time point, cannot be excluded. Most cel lular degradation and neuronal death that occurs after focal ischemia, however, is detectable within 48 h (Chen et al., 1993) . Thus, the intact cell mem branes and processes we observed in the lacZ pos itive neurons suggest that they survived the isch emic event. Whether damage to the neighboring neurons, glia, and microvasculature will ultimately contribute to the death of these neurons cannot be determined from the present results. infected striatal neurons 48 h after middle cerebral artery surgery. Data are represented as the mean percent ± SD of /acZ-expressing neurons remaining in the occluded hemi sphere versus the contralateral unoccluded hemisphere. Dif ferences in survivorship between occluded and nonoccluded hemispheres within each group were significant [i.e., signif icantly different from 100%; P < 0.05 for glucose transporter (GT) and p < 0.001 for control] and differences between GT (n = 7) and control groups (n = 9) were significant (*p = 0.022).
J Cereb Blood Flow Metab, Vol. 16, No.2, 1996 neuronal energy supplies by increasing circulating glucose levels at the time of a global hypoxic ischemic insult can be damaging, perhaps by con tributing to the increased production of lactic acid (Ginsberg et al., 1980; Pulsinelli et al., 1982) . Oth ers, however, have shown that energy supplemen tation before a focal ischemic insult or an in vivo hypoxic insult can be protective (Schurr et al., 1987; Zasslow et al., 1989; Kraft et al., 1990 ), a disparity that may reflect the relative importance of acidosis in the different models studied (Tombaugh and Sapolsky, 1990) . It is clear, however, that en ergy supplementation after a hypoxic-ischemic event is protective (Farias et al., 1990) . or the antimetabolite 3-acetylpyridine (R. . Such findings are consistent with the de layed nature of necrotic neuron death and the slow cumulative effects of the energy loss that ultimately leads to this fate. The resequestration of glutamate, restoration of ion and proton imbalances, and repair of oxidative damage place continued energetic de mands on the neuron long after the hypoxic ischemic event itself (Auer and Siesjo, 1988; Beal et al., 1991) .
Under normal circumstances the transport of glu cose from the blood to the brain exceeds the rate of neuronal glucose use by two-to fourfold (Betz et al., 1976; Gjedde, 1980) . During ischemia, however, this unidirectional transport may be reduced to the point of becoming a rate-limiting determinant of neuronal energy states (Betz et aI., 1983) . The im portance of rectifying the shortfall in glucose deliv ery that occurs during ischemia is supported by the finding that ischemia induces the expression of en dogenous GT genes in neurons, astrocytes, and mi crovessels (Lee and Bondy, 1993) . Thus, the en hancement of glucose transport by gene transfer may strengthen a natural adaptive response that al lows the restoration energy balances during the reperfusion period. In the absence of reperfusion, extracellular glucose levels remain depressed and the number of transporters becomes less relevant.
Under these circumstances it is unlikely that over-expression of either an endogenous or exogenous GT would be protective.
In this experiment only a small percentage of the striatal neuron population was targeted to overex press GT, and consequently there was no reduction on the overall extent of the MCAO lesion. Further more, there was not complete protection of all of those neurons that were targeted. The enhanced survival of individual neurons, however, is note worthy. Mechanistically, these results suggest that metabolic distress is an important contributor to the neuropathology of hypoxic-ischemic damage in the striatum. From a broader therapeutic perspective, they suggest that HSV vectors and other evolving viral vector strategies offer a promising means of delivering novel neuroprotective genes to the stria tum and elsewhere in the CNS.
